The anterior chamber of the eye as a site for pancreatic islet transplantation

Abstract

The most viable therapy for curing type 1 diabetes mellitus is pancreatic islet transplantation. However, they are unavoidable in terms of immunogenicity, which is differently affected by transplantation site. Therefore, it is necessary to determine alternate sites to permit successful islet transplantation outcomes. This paper reviews evidence that the anterior chamber of the eye (ACE) could be a good site for islet transplantation when compared to other alternate sites. In addition, this site may be a promising technical platform for noninvasive in vivo imaging of transplanted pancreatic islets.